Demographic and Traditional CVD Risk Parameters . | WHIV . | Non-HIV-Infected Women . | Whole Group . | |||
---|---|---|---|---|---|---|
Spearman ρ . | P Value . | Spearman ρ . | P Value . | Spearman ρ . | P Value . | |
Age, y | 0.26 | 0.29 | 0.25 | 0.45 | 0.27 | 0.14 |
Total cholesterol, mg/dL | 0.10 | 0.69 | 0.58 | 0.06 | 0.18 | 0.34 |
LDL-C, mg/dL | 0.005 | 0.98 | 0.67 | 0.03 | 0.16 | 0.40 |
HDL-C, mg/dL | 0.40 | 0.09 | −0.45 | 0.16 | 0.08 | 0.69 |
Triglycerides, mg/dL | 0.02 | 0.92 | 0.68 | 0.02 | 0.35 | 0.06 |
10-Year ASCVD risk score, % | 0.23 | 0.35 | −0.18 | 0.59 | 0.20 | 0.29 |
HbA1c, % | 0.51 | 0.03 | −0.04 | 0.91 | 0.33 | 0.08 |
BMI, kg/m2 | −0.01 | 0.97 | 0.24 | 0.51 | 0.04 | 0.82 |
WHR | 0.07 | 0.79 | −0.05 | 0.89 | 0.11 | 0.56 |
Time since HIV diagnosis, years | −0.26 | 0.27 | — | — | — | — |
Total duration ART, years | −0.04 | 0.88 | — | — | — | — |
CD4+ T cell count, cells/mm3 | 0.12 | 0.62 | — | — | — | — |
HIV viral load, copies/mL | 0.28 | 0.26 | — | — | — | — |
Intramyocardial lipid content and reproductive aging status (whole group) | ||||||
Reproductive aging groups | Intramyocardial lipid content, % | P value | ||||
Group 1 | 0.1 (0.1, 1.3) | 0.02 | ||||
Group 2 | 0.4 (0.3, 1.2) | |||||
Group 3 | 1.1 (0.5, 3.3) |
Demographic and Traditional CVD Risk Parameters . | WHIV . | Non-HIV-Infected Women . | Whole Group . | |||
---|---|---|---|---|---|---|
Spearman ρ . | P Value . | Spearman ρ . | P Value . | Spearman ρ . | P Value . | |
Age, y | 0.26 | 0.29 | 0.25 | 0.45 | 0.27 | 0.14 |
Total cholesterol, mg/dL | 0.10 | 0.69 | 0.58 | 0.06 | 0.18 | 0.34 |
LDL-C, mg/dL | 0.005 | 0.98 | 0.67 | 0.03 | 0.16 | 0.40 |
HDL-C, mg/dL | 0.40 | 0.09 | −0.45 | 0.16 | 0.08 | 0.69 |
Triglycerides, mg/dL | 0.02 | 0.92 | 0.68 | 0.02 | 0.35 | 0.06 |
10-Year ASCVD risk score, % | 0.23 | 0.35 | −0.18 | 0.59 | 0.20 | 0.29 |
HbA1c, % | 0.51 | 0.03 | −0.04 | 0.91 | 0.33 | 0.08 |
BMI, kg/m2 | −0.01 | 0.97 | 0.24 | 0.51 | 0.04 | 0.82 |
WHR | 0.07 | 0.79 | −0.05 | 0.89 | 0.11 | 0.56 |
Time since HIV diagnosis, years | −0.26 | 0.27 | — | — | — | — |
Total duration ART, years | −0.04 | 0.88 | — | — | — | — |
CD4+ T cell count, cells/mm3 | 0.12 | 0.62 | — | — | — | — |
HIV viral load, copies/mL | 0.28 | 0.26 | — | — | — | — |
Intramyocardial lipid content and reproductive aging status (whole group) | ||||||
Reproductive aging groups | Intramyocardial lipid content, % | P value | ||||
Group 1 | 0.1 (0.1, 1.3) | 0.02 | ||||
Group 2 | 0.4 (0.3, 1.2) | |||||
Group 3 | 1.1 (0.5, 3.3) |
Spearman ρ is shown for association between intramyocardial triglyceride content (non-normally distributed) and each baseline characteristic within all participants, WHIV, and non-HIV-infected women, respectively.
As shown above, intramyocardial triglyceride content (shown as median IQR) differed significantly across three reproductive aging groups (P = 0.02). P values <0.05 are shown in boldface.
Demographic and Traditional CVD Risk Parameters . | WHIV . | Non-HIV-Infected Women . | Whole Group . | |||
---|---|---|---|---|---|---|
Spearman ρ . | P Value . | Spearman ρ . | P Value . | Spearman ρ . | P Value . | |
Age, y | 0.26 | 0.29 | 0.25 | 0.45 | 0.27 | 0.14 |
Total cholesterol, mg/dL | 0.10 | 0.69 | 0.58 | 0.06 | 0.18 | 0.34 |
LDL-C, mg/dL | 0.005 | 0.98 | 0.67 | 0.03 | 0.16 | 0.40 |
HDL-C, mg/dL | 0.40 | 0.09 | −0.45 | 0.16 | 0.08 | 0.69 |
Triglycerides, mg/dL | 0.02 | 0.92 | 0.68 | 0.02 | 0.35 | 0.06 |
10-Year ASCVD risk score, % | 0.23 | 0.35 | −0.18 | 0.59 | 0.20 | 0.29 |
HbA1c, % | 0.51 | 0.03 | −0.04 | 0.91 | 0.33 | 0.08 |
BMI, kg/m2 | −0.01 | 0.97 | 0.24 | 0.51 | 0.04 | 0.82 |
WHR | 0.07 | 0.79 | −0.05 | 0.89 | 0.11 | 0.56 |
Time since HIV diagnosis, years | −0.26 | 0.27 | — | — | — | — |
Total duration ART, years | −0.04 | 0.88 | — | — | — | — |
CD4+ T cell count, cells/mm3 | 0.12 | 0.62 | — | — | — | — |
HIV viral load, copies/mL | 0.28 | 0.26 | — | — | — | — |
Intramyocardial lipid content and reproductive aging status (whole group) | ||||||
Reproductive aging groups | Intramyocardial lipid content, % | P value | ||||
Group 1 | 0.1 (0.1, 1.3) | 0.02 | ||||
Group 2 | 0.4 (0.3, 1.2) | |||||
Group 3 | 1.1 (0.5, 3.3) |
Demographic and Traditional CVD Risk Parameters . | WHIV . | Non-HIV-Infected Women . | Whole Group . | |||
---|---|---|---|---|---|---|
Spearman ρ . | P Value . | Spearman ρ . | P Value . | Spearman ρ . | P Value . | |
Age, y | 0.26 | 0.29 | 0.25 | 0.45 | 0.27 | 0.14 |
Total cholesterol, mg/dL | 0.10 | 0.69 | 0.58 | 0.06 | 0.18 | 0.34 |
LDL-C, mg/dL | 0.005 | 0.98 | 0.67 | 0.03 | 0.16 | 0.40 |
HDL-C, mg/dL | 0.40 | 0.09 | −0.45 | 0.16 | 0.08 | 0.69 |
Triglycerides, mg/dL | 0.02 | 0.92 | 0.68 | 0.02 | 0.35 | 0.06 |
10-Year ASCVD risk score, % | 0.23 | 0.35 | −0.18 | 0.59 | 0.20 | 0.29 |
HbA1c, % | 0.51 | 0.03 | −0.04 | 0.91 | 0.33 | 0.08 |
BMI, kg/m2 | −0.01 | 0.97 | 0.24 | 0.51 | 0.04 | 0.82 |
WHR | 0.07 | 0.79 | −0.05 | 0.89 | 0.11 | 0.56 |
Time since HIV diagnosis, years | −0.26 | 0.27 | — | — | — | — |
Total duration ART, years | −0.04 | 0.88 | — | — | — | — |
CD4+ T cell count, cells/mm3 | 0.12 | 0.62 | — | — | — | — |
HIV viral load, copies/mL | 0.28 | 0.26 | — | — | — | — |
Intramyocardial lipid content and reproductive aging status (whole group) | ||||||
Reproductive aging groups | Intramyocardial lipid content, % | P value | ||||
Group 1 | 0.1 (0.1, 1.3) | 0.02 | ||||
Group 2 | 0.4 (0.3, 1.2) | |||||
Group 3 | 1.1 (0.5, 3.3) |
Spearman ρ is shown for association between intramyocardial triglyceride content (non-normally distributed) and each baseline characteristic within all participants, WHIV, and non-HIV-infected women, respectively.
As shown above, intramyocardial triglyceride content (shown as median IQR) differed significantly across three reproductive aging groups (P = 0.02). P values <0.05 are shown in boldface.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.